Skip to main content
. 2000 May;20(9):3286–3291. doi: 10.1128/mcb.20.9.3286-3291.2000

FIG. 4.

FIG. 4

No elevated sensitivity to camptothecin or 4-NQO in WRN−/−;BLM+/− embryonic fibroblasts. (a) Camptothecin treatment. (b) 4-NQO treatment. y axis represents the number of cells in the treated well divided by the number of cells in the control well.